Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility
Jin Medical International (NASDAQ:ZJYL) has launched production at Plant No. 3 of its intelligent manufacturing facility in Chuzhou, Anhui, China. The state-of-the-art facility features robotic arms and temperature-controlled workshops with an annual production capacity of 200,000 units.
The company, leveraging 19 years of rehabilitation technology expertise, manufactures various products including ultra-light wheelchairs, Paralympic-certified competition equipment, micro hyperbaric oxygen chambers, and beauty devices. The facility meets Japanese Industrial Standards (JIS) certification requirements and is preparing to supply electric wheelchairs to markets in Istanbul, Jerusalem, and Tokyo.
Jin Medical International (NASDAQ:ZJYL) ha avviato la produzione presso l'impianto n. 3 della sua struttura di produzione intelligente a Chuzhou, Anhui, Cina. Questa struttura all'avanguardia è dotata di bracci robotici e laboratori a temperatura controllata, con una capacità produttiva annua di 200.000 unità.
L'azienda, forte di 19 anni di esperienza nella tecnologia per la riabilitazione, produce diversi prodotti tra cui sedie a rotelle ultraleggere, attrezzature certificate per competizioni paralimpiche, camere iperbariche micro e dispositivi per la bellezza. La struttura soddisfa i requisiti di certificazione degli Standard Industriali Giapponesi (JIS) e si sta preparando a fornire sedie a rotelle elettriche ai mercati di Istanbul, Gerusalemme e Tokyo.
Jin Medical International (NASDAQ:ZJYL) ha iniciado la producción en la Planta Nº 3 de su instalación de fabricación inteligente en Chuzhou, Anhui, China. Esta instalación de última generación cuenta con brazos robóticos y talleres con control de temperatura, con una capacidad de producción anual de 200,000 unidades.
La compañía, con 19 años de experiencia en tecnología de rehabilitación, fabrica diversos productos que incluyen sillas de ruedas ultraligeras, equipos certificados para competencias paralímpicas, cámaras micro de oxígeno hiperbárico y dispositivos de belleza. La instalación cumple con los requisitos de certificación de los Estándares Industriales Japoneses (JIS) y se está preparando para suministrar sillas de ruedas eléctricas a los mercados de Estambul, Jerusalén y Tokio.
Jin Medical International (NASDAQ:ZJYL)은 중국 안후이성 추저우에 위치한 지능형 제조 시설 3호 공장의 생산을 시작했습니다. 이 최첨단 시설은 로봇 팔과 온도 조절 작업장을 갖추고 있으며 연간 생산 능력은 200,000대입니다.
회사는 19년간의 재활 기술 전문성을 바탕으로 초경량 휠체어, 패럴림픽 인증 경기 장비, 마이크로 고압 산소 챔버, 미용 기기 등 다양한 제품을 제조합니다. 이 시설은 일본 산업 표준(JIS) 인증 요건을 충족하며, 이스탄불, 예루살렘, 도쿄 시장에 전동 휠체어를 공급할 준비를 하고 있습니다.
Jin Medical International (NASDAQ:ZJYL) a lancé la production dans l'usine n°3 de son installation de fabrication intelligente à Chuzhou, Anhui, Chine. Cette installation ultramoderne est équipée de bras robotiques et d'ateliers à température contrôlée, avec une capacité de production annuelle de 200 000 unités.
L'entreprise, forte de 19 ans d'expertise en technologie de réhabilitation, fabrique divers produits, notamment des fauteuils roulants ultra-légers, du matériel de compétition certifié paralympique, des chambres d'oxygène hyperbare micro et des appareils de beauté. L'installation répond aux exigences de certification des Normes Industrielles Japonaises (JIS) et se prépare à fournir des fauteuils roulants électriques aux marchés d'Istanbul, Jérusalem et Tokyo.
Jin Medical International (NASDAQ:ZJYL) hat die Produktion in Werk Nr. 3 seiner intelligenten Fertigungsanlage in Chuzhou, Anhui, China, aufgenommen. Die hochmoderne Anlage verfügt über Roboterarme und temperaturkontrollierte Werkstätten mit einer jährlichen Produktionskapazität von 200.000 Einheiten.
Das Unternehmen nutzt 19 Jahre Erfahrung in der Rehabilitationstechnologie und stellt verschiedene Produkte her, darunter ultraleichte Rollstühle, paralympisch zertifizierte Wettkampfausrüstung, mikro-hyperbare Sauerstoffkammern und Schönheitsgeräte. Die Anlage erfüllt die Anforderungen der japanischen Industriestandards (JIS) und bereitet sich darauf vor, elektrische Rollstühle für die Märkte in Istanbul, Jerusalem und Tokio zu liefern.
- New Plant No. 3 adds significant production capacity of 200,000 units annually
- Facility meets Japanese Industrial Standards (JIS) certification requirements
- Geographic expansion into multiple international markets including Turkey, Israel, and Japan
- Diversified product portfolio spanning medical rehabilitation to lifestyle aesthetics
- None.
Insights
Jin Medical's new Plant No. 3 significantly expands production capacity to 200,000 units annually, strengthening global distribution capabilities.
Jin Medical's launch of production at Plant No. 3 represents a significant capacity expansion in their Chuzhou manufacturing facility. The implementation of advanced manufacturing technologies—including robotic arms, temperature-controlled workshops, and laser-welding capabilities—indicates a substantial investment in precision manufacturing. The 200,000-unit annual production capacity is particularly noteworthy as it provides Jin Medical with the scale necessary to pursue meaningful global market penetration.
The facility's adherence to Japanese Industrial Standards (JIS) certification demonstrates a commitment to quality manufacturing that will be crucial for international market acceptance. This certification is especially important in medical devices where regulatory compliance and quality assurance are paramount for market entry. The combination of high-volume production capabilities with stringent quality standards positions Jin Medical to effectively compete in both price-sensitive and quality-demanding markets.
From a supply chain perspective, this expansion enables Jin Medical to vertically integrate more of their production processes, potentially reducing dependency on external suppliers while increasing control over quality and costs. The timing of this production capacity coming online coincides with their stated international distribution plans to markets including Turkey, Israel, and Japan, suggesting a well-coordinated expansion strategy that aligns manufacturing capabilities with market development initiatives. The geographic diversity of these target markets indicates a strategic approach to risk distribution across different regional economies.
Jin Medical's product diversification strategy reveals a calculated expansion beyond traditional rehabilitation equipment. Their portfolio now spans from ultra-lightweight wheelchairs (5.5 kg) to specialized equipment meeting International Paralympic Committee standards, alongside micro hyperbaric oxygen chambers and beauty devices. This product mix indicates a deliberate bridging of medical rehabilitation with wellness and lifestyle markets—sectors with different regulatory requirements, purchase cycles, and consumer behaviors.
The company's focus on Paralympic-certified equipment is particularly strategic, as this specialized market segment demands exacting performance standards but typically commands premium pricing and faces less competition from mass-market manufacturers. Meanwhile, the expansion into micro hyperbaric oxygen chambers represents entry into the growing home medical equipment sector, where consumers increasingly seek professional-grade therapeutic devices for personal use.
Perhaps most telling is Jin Medical's venture into beauty devices, signaling a recognition that the boundaries between medical, wellness, and aesthetic products are increasingly blurred in consumer markets. This cross-category approach allows the company to leverage core engineering competencies across multiple product lines while potentially smoothing revenue fluctuations through diversification.
The global distribution strategy targeting senior care communities in Istanbul, rehabilitation centers in Jerusalem, and home clinics in Tokyo demonstrates a nuanced understanding of how rehabilitation needs vary by region and cultural context. This targeted approach, rather than a generic global rollout, suggests Jin Medical has conducted detailed market research to identify specific institutional customers with defined needs matching their expanded production capabilities.
Beijing, China, July 15, 2025 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (Nasdaq: ZJYL) (“Jin Medical”, and together with all its subsidiaries, the “Company”), a Nasdaq-listed provider of rehabilitation medical equipment, announced today that its wholly owned subsidiary, ZhongJin Medical Equipment (Anhui) Co., Ltd. (“Zhongjin Anhui”), has officially launched production at Plant No. 3 of Zhongjin Anhui’s intelligent manufacturing facility in Chuzhou, Anhui, China. With 19 years of expertise in rehabilitation technology, the Company is committed to accelerate the integration of the global rehabilitation device supply chain through its robust production and precision manufacturing capabilities.
At Zhongjin Anhui’s intelligent manufacturing facility in Chuzhou, robotic arms operate with precision in temperature-controlled workshops, while sapphire sparks ignite as aluminum-alloy frames are laser-welded. This high-powered engine of innovation—capable of producing 200,000 units annually—brings Japanese Industrial Standards (JIS)-certified quality into every seam, laying a strong foundation for Jin Medical’s steady expansion across regional frontiers.
Jin Medical is continuously expanding its product ecosystem, bridging rehabilitation and broader health needs. The Company’s products span across the 5.5 kg ultra-light wheelchair, competition-grade equipment certified by the International Paralympic Committee, micro hyperbaric oxygen chambers dedicated to health and wellness and beauty devices that extend into lifestyle aesthetics. Driven by a cross-disciplinary innovation mandate, the Company is uniquely positioned to anticipate and address the evolving health needs of diverse regions and populations.
“We are witnessing a historic shift in rehabilitation technology—from basic functional support to the pursuit of quality living,” Dr. Wang Erqi, Jin Medical’s CEO and Chairman of the Board, remarked. “When intelligent manufacturing in China meets insights into global demands, health solutions that put people first emerge.”
As of the date hereof, the latest batch of electric wheelchairs is undergoing rigorous vibration testing. The Company plans to supply these units to senior care communities in Istanbul, rehabilitation centers in Jerusalem, and home clinics in Tokyo. With these products, Jin Medical is committed to using technology to overcome geography and access barriers.
Along this new Silk Road of rehabilitation technology that connects the East and the West, Jin Medical’s story on the global stage is only at its prologue.
About Jin Medical International Ltd.
Founded in 2006 and headquartered at Changzhou, Jiangsu Province of China, Jin Medical designs, develops, manufactures and markets wheelchairs and living aids products for people with disabilities, elderlies, and for rehabilitation application. Currently, Jin Medical already operates two manufacturing plants of approximately 230,000 square feet in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. Jin Medical is currently establishing a new facility with 430,000 square feet in Chuzhou, Anhui Province, China. Jin Medical works with more than 40 distributors in China and more than 20 international distributors. The majority of Jin Medical’s wheelchair products, with more than 30 models, are sold to distributors in Japan and China. Jin Medical continuously delivers innovative wheelchair products that are both lightweight and ergonomic. For more information, please visit: http://www.zhjmedical.com.
Forward-Looking Statement
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “should,” “intend,” “plan,” “strive,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company’s ability to achieve its goals and strategies, the Company’s future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, import and export restrictions, fluctuations in general economic and business conditions, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission (“SEC”). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
For more information, please contact:
ir@zhjmedical.com
FAQ
What is the annual production capacity of Jin Medical's (ZJYL) new Plant No. 3 in Chuzhou?
What types of products does Jin Medical (ZJYL) manufacture?
Which international markets will Jin Medical (ZJYL) supply from its Chuzhou facility?
What certifications does Jin Medical's (ZJYL) Chuzhou manufacturing facility have?
How many years of experience does Jin Medical (ZJYL) have in rehabilitation technology?
